SRI Surgical Reports Results for Fourth Quarter and Fiscal Year 2008


TAMPA, Fla., March 2, 2009 (GLOBE NEWSWIRE) -- SRI/Surgical Express, Inc. (SRI) (Nasdaq:STRC), a leading provider of reusable surgical device reprocessing services supporting the healthcare industry, today announced financial results for its fourth quarter and year ended December 31, 2008.

For the fourth quarter of 2008, SRI Surgical reported total revenue of $23,988,000, an increase of $32,000 over the fourth quarter of 2007. The net loss for the fourth quarter of 2008 was $699,000 or $0.11 per basic and diluted common share compared to a net loss for the fourth quarter of 2007 of $1,617,000 or $0.26 per basic and diluted common share. Revenues for the fiscal year ended December 31, 2008 were $97,028,000, compared to $94,201,000 for the fiscal year ended December 31, 2007. The net loss for the fiscal year ended December 31, 2008 was $2,556,000 or $0.40 per basic and diluted common share compared to a net loss of $3,193,000, or $0.50 per basic and diluted common share for the fiscal year ended December 31, 2007.

Gerald Woodard, Chief Executive Officer said, "Having completed my first year as CEO, I am encouraged by the progress we have made. We successfully completed a supply and co-marketing agreement with Cardinal Health, whereby we will jointly develop, market and distribute a new product offering, the Hybrid Preference Pack(tm). Last month we began the process of closing our disposable products assembly plant and now buy all our disposable surgical kits directly from Cardinal, a more cost effective alternative. We have strong product and service offerings and motivated employees. Though the recession is a challenge for all businesses, we look forward to 2009."

About SRI Surgical

SRI Surgical (www.srisurgical.com) provides central processing and supply chain management services to hospitals and surgery centers across the United States. SRI Surgical serves hospitals and surgery centers in 19 states from 10 reprocessing facilities and four distribution centers located throughout the United States.

The SRI/Surgical Express, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4997

Forward-Looking Statements

The statements in this press release that are not historical, including statements regarding SRI Surgical's beliefs, expectations, and strategies, constitute "forward looking statements" within the meaning of the federal securities laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements. Important factors that could cause the differences are discussed in SRI Surgical's reports on Forms 10-Q, 10-K, and 8-K that the Company periodically files with the Securities and Exchange Commission. These factors include SRI Surgical's sales process and market acceptance of its products and services, SRI Surgical's capital needs, its dependence on significant customers and a significant supplier, risks of a new product offering, and the competitive healthcare marketplace. SRI Surgical does not undertake to update any forward-looking statements in this press release. Copies of SRI Surgical's SEC filings, including its annual report on Form 10-K and quarterly reports on Form 10-Q, may be obtained by contacting SRI Surgical's investor relations department at (813) 891-9550 or at the Investors section of the SRI Surgical Website at www.srisurgical.com.


                       SRI/SURGICAL EXPRESS, INC.
                    Condensed Statements of Operations
                  (In thousands, except per share data)
                               (unaudited)

                                Three Months Ended  Twelve Months Ended
                                    December 31,        December 31,
                                   2008      2007      2008      2007
                                   ----      ----      ----      ----
 Revenues                        $23,988   $23,956   $97,028   $94,201
 Cost of revenues                 18,767    19,216    75,599    73,947
                                 -------   -------   -------   -------
  Gross profit                     5,221     4,740    21,429    20,254

 Distribution expenses             1,752     1,699     7,227     6,394
 Selling and administrative
  expenses                         4,247     5,379    16,289    17,775
                                 -------   -------   -------   -------
  Loss from operations              (778)   (2,338)   (2,087)   (3,915)

 Interest expense                    246       317     1,077     1,385
 Other income                       (121)      (92)     (396)     (342)
                                 -------   -------   -------   -------
  Loss before income taxes          (903)   (2,563)   (2,768)   (4,958)

 Income tax benefit                 (204)     (946)     (212)   (1,765)
                                 -------   -------   -------   -------
  Net loss                       $  (699)  $(1,617)  $(2,556)  $(3,193)
                                 =======   =======   =======   =======

 Basic loss per common share     $ (0.11)  $ (0.26)  $ (0.40)  $ (0.50)
                                 =======   =======   =======   =======
 Weighted average common shares
  outstanding, basic               6,440     6,339     6,434     6,399
                                 =======   =======   =======   =======
 Diluted loss per common share   $ (0.11)  $ (0.26)  $ (0.40)  $ (0.50)
                                 =======   =======   =======   =======
 Weighted average common shares
  outstanding, diluted             6,440     6,339     6,434     6,399
                                 =======   =======   =======   =======


                        SRI/SURGICAL EXPRESS, INC.
                        Condensed Balance Sheets
                              (In thousands)
                               (unaudited)

                                                      As of     As of
                                                     Dec 31,   Dec 31,
                                                      2008      2007
                                                     -------   -------


 Cash and cash equivalents                           $   484   $   656
 Accounts receivable, net                             11,200    11,613
 Inventories, net                                      5,727     6,159
 Prepaid expenses and other assets                     2,271     2,847
 Reusable surgical products, net                      20,577    19,416
 Property, plant and equipment, net                   29,487    31,277
                                                     -------   -------

  Total assets                                       $69,746   $71,968
                                                     =======   =======


 Notes payable                                       $ 8,434   $ 2,493
 Accounts payable                                      8,461     7,984
 Accrued expenses                                      5,121     5,464
 Mortgage payable                                      4,228     4,286
 Bonds payable                                           520     7,060
 Deferred tax liability, net                              --        55
                                                     -------   -------

   Total liabilities                                  26,764    27,342

   Shareholders' equity                               42,982    44,626
                                                     -------   -------

   Total liabilities and shareholders' equity        $69,746   $71,968
                                                     =======   =======


            

Contact Data